Q&A with Tracy Warren
Co-Founder and CEO of Astarte Medical
Family Office Insights sits down with Tracy Warren, (Co-Founder and CEO) to discuss her company, Astarte Medical, a software as a service (SaaS) and data as a service (DaaS) platform that quantifies gut health in the first 1000 days of life, which spans from prenatal care to early infant nutrition. Astarte Medical is initially launching the NICUtrition® suite of products focused on optimizing nutrition and gut health for the smallest and highest risk patients – preterm infants. The company has been founder funded to date and is actively raising its $4M Series A round, led by Keiretsu MidAtlantic. Milestones for the funding include first customers and steady revenue, a validation study of the gut health score on over 1000 infants, and recruitment of our initial sales and marketing resources to achieve scale.
Please join Family Office Insights for this gathering on Thursday, October 18th, 2018 to learn more about Astarte Medical.
Family Office Insights
PRESENTS: Astarte Medical
Family Office Insights is a voluntary, “opt-in” collaborative peer-to-peer community of single family offices, qualified investors and institutional investors. Join the community here www.familyofficeinsights.com
As co-founder and CEO of Astarte Medical, Tracy leverages her experience in entrepreneurship and nearly two decades as an early stage venture capital investor. In this role, she provides strategic direction for the business to improve outcomes for our most vulnerable patients, preterm infants.
Having been a general partner in venture prior to founding Astarte, Tracy has acute knowledge of the needs of investors and key stakeholders to match the value of the business and balance capital requirements to maximize return potential as well as make a demonstrable impact on the lives of babies.
Tracy previously co-founded Astarte Ventures, an early stage investment firm focused exclusively on investing in companies with technologies to support women’s and children’s health and wellbeing. This passive portfolio includes eight companies supporting this market focus. It was through the efforts associated with Astarte Ventures, Tracy and her co-founders came together to form Astarte Medical to dramatically impact health outcomes in the first 1000 days of life, from conception through age 2.
Prior to Astarte, Tracy served as general partner at Battelle Ventures and focused on investments in health & life sciences, as well as emerging energy technologies. She led investments leveraging technologies licensed from top research institutions, including Princeton University, California Institute of Technology, University of Pennsylvania and Oak Ridge National Laboratory. Tracy led the firm’s investments in NuPathe (NASDAQ: PATH; acquired by Teva Pharmaceuticals for $140 million), BioNano Genomics (NASDAQ: BNGO), Micro Interventional Devices, and SmartSynch (sold to Itron for $100 million).
Tracy has been working with institutions to commercialize groundbreaking science since 2003. During that time she has worked closely with the technology transfer and economic development organizations in medical centers, universities and national laboratories. This experience led Tracy to found FedIMPACT, LLC in 2014, a commercialization enterprise to identify and launch technologies from federal laboratories. Having successfully spun-out four companies in just 18 months with over $5M of funding, FedIMPACT was acquired by IP Group, plc in December 2016.
In 2007, while at Battelle Ventures, Tracy co-founded NellOne Therapeutics, a biotechnology company focused on soft tissue regeneration.
Leveraging her vast experience in commercializing technologies from the nation’s leading institutions, Tracy serves on the Board of the Research Education and Innovation (REI) Board at Children’s National Medical Center (Washington, DC) where she chairs the Technology & Innovation Advisory Committee, and formerly served on the Board of Clemson University Research Foundation.
Tracy received her BS in Accounting and International Business from New York University and her MBA at Columbia Business School in Finance.
If you have any questions, please email Tracy at: firstname.lastname@example.org.